T-box transcription factor 22 (TBX22)

T-box transcription factor 22 (TBX22) is a member of the T-box family of transcription factors, characterized by a conserved DNA-binding T-domain. TBX22 regulates genes crucial for craniofacial development, especially palatogenesis. Mutations in TBX22 cause X-linked cleft palate with or without ankyloglossia, a genetic disorder affecting palate closure and tongue formation. The gene encodes a 400-amino acid protein and is located on chromosome Xq21.1. TBX22 is specifically expressed in the palatal shelves and tongue during embryonic development and plays a critical role in morphogenesis and organogenesis of the craniofacial region. There is no evidence that TBX22 itself is a conventional therapeutic target, receptor, enzyme, transporter, or a drug-accessible protein. It is a developmental transcription factor and thus is currently not directly targeted by drugs. No interacting drugs, mechanisms of action, biomarkers, or safety concerns related to therapeutic targeting are reported in the available reference sources for TBX22.

Other names

T-box transcription factor TBX22TBX22TBOX22T-box protein 22ABERSCLPACPXTBXXdJ795G23.1T-box 22